Welcome to LookChem.com Sign In|Join Free

CAS

  • or

198211-96-0

Post Buying Request

198211-96-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

198211-96-0 Usage

General Description

2-[4-[2-[4-(6-Aminopyridin-2-yl)phenyl]ethyl]piperazin-1-yl]-1-phenylethanone, also known as BMS-747158-02, is a chemical compound with a complex structure. It contains a piperazine ring, a phenyl ring and multiple functional groups including an amine and a pyridine. 2-[4-[2-[4-(6-Aminopyridin-2-yl)phenyl]ethyl]piperazin-1-yl]-1-phenylethanone is a potential pharmaceutical agent and has been studied for its potential therapeutic applications in the treatment of various conditions. It may have interactions with various biological systems and receptors, and could potentially be used in the development of new drugs. The compound's chemical structure and properties make it an interesting subject for further research in the field of medicinal chemistry and pharmacology.

Check Digit Verification of cas no

The CAS Registry Mumber 198211-96-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,8,2,1 and 1 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 198211-96:
(8*1)+(7*9)+(6*8)+(5*2)+(4*1)+(3*1)+(2*9)+(1*6)=160
160 % 10 = 0
So 198211-96-0 is a valid CAS Registry Number.

198211-96-0Downstream Products

198211-96-0Relevant articles and documents

New pharmaceutical combinations for NOS inhibitors

-

, (2008/06/13)

The present invention relates to new pharmaceutical uses for compounds that exhibit activity as nitric oxide synthase (NOS) inhibitors. Specifically, it relates to the use of NOS inhibitors, particularly selective neuronal NOS (nNOS) inhibitors, alone or in combination with another active agent, in particular, either an SSRI or an NK-1 receptor antagonist, for the treatment of disorders or conditions the treatment which can be effected or facilitated by altering circadian rhythms. Examples of such disorders and conditions are blindness, obesity, seasonal affective disorder, bipolar disorder; jet lag, circadian sleep rhythms disorder, sleep deprivation, parasomnias, REM sleep disorders, hypersomnia, sleep-wake cycle disorders, narcolepsy and sleep disorders associated with shift work or irregular work schedules; nocturnal enuresis, and restless-legs syndrome.

6-phenyl-pyridin-2-ylamine derivatives

-

, (2008/06/13)

The present invention relates to certain 6-phenyl-pyridin-2-ylamine derivatives that exhibit activity as nitric oxide synthase (NOS) inhibitors, to pharmaceutical compositions containing them and to their use in the treatment and prevention of central nervous system disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 198211-96-0